Skip to main content

Special Issues

Clinical Trials

Pirtobrutinib in Covalent BTKi-Treated Patients With CLL/SLL: Translating Clinical Trial Insights Into Real-World Practice

Managing Side Effects of Antibody–Drug Conjugate (ADC) Therapy: A Guide for Patients With Metastatic Breast Cancer

Clinical Trials

AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer

Clinical Trials

The Evolution of Abemaciclib Clinical Trial Data for the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer

Clinical Trials

Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes

Clinical Trials

Pirtobrutinib in Pretreated Patients With CLL/SLL: Applying Lessons From Clinical Trials to Clinical Practice

2023 Year in Review - Cholangiocarcinoma

A Guide Through the Metastatic Breast Cancer Patient Journey: Focus on HER2+/HER2-Low ADC Therapy

Real-World Uptake and Utilization Patterns of Biosimilars in Clinical Practice

The Pharmacist and Patients With HER2-Positive or HER2-Low Metastatic Breast Cancer: Navigating the Treatment Landscape

1
2
3
4

Page 1 of 6
Results 1 - 10 of 59